Litcius/Paper detail

Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α

Manne Munikumar, Giridhar Goudar, Seshadri Reddy Varikasuvu, Mahadev C. Khetagoudar, Kanipakam Hema, Pradeep Natarajan, Muni Divya Ummiti, Vijay Yenagi, Sridhar Chinthakindi, P Dharani, Durga Sai Sri Thota, Sameer Patil, Vijaylaxmi Patil

20213 Biotech27 citationsDOIOpen Access PDF

Topics & Concepts

In silicoCytokine stormPharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug discoveryDocking (animal)ChemistryCoronavirusProteaseCoronavirus disease 2019 (COVID-19)BerberineDrugComputational biologyBiologyBiochemistryMedicineEnzymeInfectious disease (medical specialty)NursingPathologyDiseaseGenePhytochemicals and Medicinal PlantsSARS-CoV-2 and COVID-19 ResearchDiverse Scientific Research Studies
Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α | Litcius